Biochemicals and Reagents

4-Hydroxy darunavir is a research tool that is used to study the function of ion channels, receptors and other biomolecules. It is an activator ligand that binds to the receptor and activates the cell. 4-Hydroxy darunavir has been shown to inhibit the activity of drug efflux pumps in bacteria, which may contribute to its anti-bacterial properties.

Miclxin is a peptide that is used as a research tool in the field of pharmacology and cell biology. Miclxin binds to ion channels and inhibits their function, which may be due to its ability to inhibit ligand binding. Miclxin has been shown to act as an activator or inhibitor of ion channels. It has been shown to have high purity and is available for purchase at a CAS number of 2494198-61-5.

CP-96345 is a peptide hormone that inhibits the release of inflammatory substances, such as substance P and prostaglandin E2. It has been shown to be effective in the treatment of bowel disease, including Crohn's disease and ulcerative colitis, as well as infectious diseases. CP-96345 inhibits neurokinin-1 receptor activation by binding to it and blocking its access to substances. This inhibition leads to an inhibition of the release of substance P, which is an important mediator for pain, inflammation, and disease activity. CP-96345 has also been shown to have cardioprotective effects in animal models by reducing oxidative injury caused by ischemia/reperfusion injury.

BSJ-03-123 is a ubiquitin ligase inhibitor that inhibits the ubiquitin-proteasome system. It has been shown to be effective in the treatment of leukemia cells and other cancers, such as prostate cancer. BSJ-03-123 inhibits the degradation of proteins by the proteasome, which leads to an accumulation of ubiquitinated proteins and cell death. This drug is not cytotoxic to normal cells, but it does cause apoptosis in cancer cells. The mechanism of action of BSJ-03-123 involves inhibition of the degraders that degrade ubiquitinated proteins and profiling studies have shown that its hydroxyl group may be responsible for this activity.

TOK-8801 is a thiazole-2-carboxamide compound that has immunomodulatory, immunopharmacological, and antigen properties. TOK-8801 induces a delayed type hypersensitivity response in mice and inhibits the proliferation of human T cells by inhibiting the binding of CD28 to B7.1 or B7.2. It also has been shown to suppress the growth of T cells by inhibiting IL-2 production and enhance the function of macrophages by inducing IL-12 secretion. TOK-8801 is being investigated as a potential treatment for autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis.

GW-406381 is a potent and selective agonist for the peroxisome proliferator-activated receptor delta (PPARδ), which is commonly employed in pharmacological research. This compound functions as a ligand that activates PPARδ, a nuclear receptor that plays a critical role in the regulation of lipid metabolism, energy homeostasis, and inflammatory responses. By binding to the PPARδ receptor, GW-406381 modulates the transcription of target genes involved in fatty acid oxidation, mitochondrial biogenesis, and muscle fiber type switching.

Amelubant is a synthetic compound designed for use in detailed biochemical research and therapeutic investigations. As a product derived from innovative chemical synthesis techniques, Amelubant is engineered to interact with particular biological pathways, predominantly in the field of inflammatory response modulation. Its mode of action involves specific binding to target receptors, influencing downstream signaling cascades.

Temarotene is an all-trans retinoic acid (ATRA) analog that binds to the IL-2 receptor with high affinity and specificity. It has been shown to inhibit the proliferation of HL-60 cells in vitro, which may be due to its ability to induce the release of colony-stimulating factor from these cells. Temarotene also enhances the uptake of ATRA by HL-60 cells and increases the expression of receptors for ATRA in humans. In vivo studies have shown that temarotene is a potent inducer of fatty acid synthesis in Sprague-Dawley rats. This agent has a long half-life and is rapidly absorbed when administered orally, with peak plasma concentrations occurring 2 hours after administration. The pharmacokinetic properties of this drug are similar to those of other synthetic retinoids, such as all-trans-retinoic acid.

CDM-NAG is a specialized biochemical substrate, which is a chemical compound derived from the structural modification of chitin. It has been engineered to act as a chromogenic or fluorescent marker due to its functional groups that undergo changes upon enzymatic action. The mode of action involves hydrolysis by N-acetylglucosaminidases, enzymes that recognize and cleave specific glycosidic bonds within the substrate. Upon enzymatic cleavage, CDM-NAG releases a measurable signal, either through colorimetric change or fluorescence, enabling precise quantification of enzyme activity.

MDL 19301 is a high-affinity antagonist of the nicotinic acetylcholine receptor, specifically the alpha4beta2 subtype. It has been shown to inhibit the binding of nicotine and other nicotinic agonists to receptors in cell culture. MDL 19301 has also been shown to inhibit the release of acetylcholine from nerve endings in rat ileum, suggesting that it may have therapeutic applications for treatment of neurodegenerative disorders such as Alzheimer's disease or Parkinson's disease.

MK-2461 is an orally bioavailable small molecule that binds to the epidermal growth factor receptor (EGFR) and inhibits its downstream signaling. It has been shown to have potent antitumor activity in cell culture and in vivo against a range of tumor types. MK-2461 binds to the EGFR with high affinity, inhibiting the downstream signaling pathway by blocking the activation of molecules such as Raf, MEK1/2, and ERK1/2. The binding site of MK-2461 is located on the extracellular domain of EGFR.

Wee1 is a cell factor that plays an important role in the regulation of transcription. Wee1 is involved in the regulation of p21, which is a tumor suppressor gene that inhibits cell proliferation. Wee1 may be involved in cancer and stem cell production. Studies have shown that Wee1 is expressed at high levels in women and has been shown to regulate genes that are important for female fertility. Wee1 interacts with factors such as p21 and transcriptional regulators to control the expression of genes related to the immune response, inflammation, and angiogenesis. The expression of Wee1 has also been shown to be regulated by HIF-1α, which plays a key role in tumorigenesis and cellular apoptosis. The inhibition of Wee1 can inhibit endothelial cell proliferation through the inhibition of GSK3β phosphorylation, which results in increased levels of cyclin D2 (CCND2) protein.

1-[[4-(2-Benzothiazolyloxy)phenyl]methyl]-4-piperidinecarboxylic acid is a research tool for studying ligand-receptor interactions and ion channels. It is a high purity, water soluble compound that is stable to hydrolysis. The compound has been shown to inhibit the activity of some proteins including Protein Kinase C (PKC), phospholipase A2, and adenylate cyclase. 1-[[4-(2-Benzothiazolyloxy)phenyl]methyl]-4-piperidinecarboxylic acid has been shown to affect the pharmacology of peptides. It can be used in cell biology as an antibody or as a protein interaction inhibitor.

(R)-N-(5-(tert-Butyl)-1H-pyrazol-3-yl)-2-(3-isopropylpiperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine is a chemical inhibitor that binds to the cytoskeletal protein, cilium. It has been shown to inhibit the movement of cilia in cells and prevent the disassembly of these structures. (R)-N-(5-(tert-Butyl)-1H-pyrazol-3-yl)-2-(3-isopropylpiperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-4 -amine also inhibits dna replication and cell growth by blocking the production of proteins vital for this process. This drug has been used to study the mechanisms involved in dna replication and

Cyprodinil-13C6 is a cationic compound that has been shown to activate IL-17A, an important cytokine involved in immune responses. It exhibits a unique coordination geometry and forms complex molecules with malondialdehyde, a reactive aldehyde. In the field of Life Sciences, Cyprodinil-13C6 has been extensively studied for its ability to neutralize chemokines and inhibit lipid peroxidation. It has also been found to have a protective effect on inositol and reactive oxygen species in human serum. With its diverse range of properties, Cyprodinil-13C6 holds great potential for various applications in research and development.

ITMN 4077 is an ion channel activator that belongs to the group of peptides. It is a synthetic peptide with a high purity, and has been shown to be an inhibitor of sodium channels in neuronal cells. ITMN 4077 may be used as a research tool to study protein interactions, such as those between ion channels and their ligands. This compound may also be used for pharmacological purposes or for the treatment of diseases caused by abnormal ion channel activity, such as epilepsy or chronic pain.

Actinoramide A is a marine natural product that belongs to the class of fatty acids. It is a type strain and has been shown to have antimicrobial properties. Whole-genome sequencing was performed on Actinoramide A, which revealed that it is synthesized by a marine microorganism of the genus Actinomycetospora. The gene sequence analysis revealed that this compound contains tetrapeptides and histone lysine residues, which may contribute to its antimicrobial activity.

PBI-4050 sodium is a growth factor that has been shown to stimulate the growth of lung fibroblasts and improve histology in an animal model. PBI-4050 sodium activates cells, which are seen as polymorphs under the microscope. It has also been shown to be effective against idiopathic pulmonary fibrosis in humans. PBI-4050 sodium has been shown to act through a number of mechanisms, including stimulating the release of adipose tissue fatty acids, which may alleviate insulin resistance and ventricular dysfunction.

Imidazo[1,2-a]pyridin-2(3H)-one is a heterocyclic compound, which is a member of the imidazopyridine class. This compound is synthesized through various organic reactions involving the cyclization of precursor molecules, often incorporating nitrogen atoms into its ring structure. Its mode of action typically involves interaction with specific biological targets, such as receptors or enzymes, where it can modulate physiological responses. The compound acts through binding at allosteric sites, often influencing the activity of central nervous system receptors or enzymes involved in cellular signaling pathways.

Ce3F4 analog 1 is a protein that belongs to the class of ligands, which are organic molecules that bind to receptors. It has been shown to be an inhibitor of ion channels, such as potassium and calcium channels. Ce3F4 analog 1 is a high-purity, recombinant peptide with a purity of >98% and an activity of >90%. Ce3F4 analog 1 is also known as Cas No. 2141967-43-1 and can be used as a research tool in the fields of pharmacology, cell biology, and antibody production.

Lin28-let-7a antagonist 1 is a small molecule inhibitor, which is a chemically synthesized compound with significant therapeutic potential. It acts by targeting the Lin28/let-7 axis, a critical regulatory pathway involved in cellular processes such as development, metabolism, and tumorigenesis. The source of this antagonist is a synthetic, rationally designed compound, optimized for high specificity and potency.

Inhibits lymphocyte adhesion to mucosal endothelium; Crohn's disease therapy

AES-350 is a peptide that is used as a research tool to study the activation and inhibition of receptor proteins. The sequence of this peptide is derived from the C-terminal region of the calcitonin gene-related peptide (CGRP). It interacts with the CGRP receptor protein, which is an ion channel protein that regulates calcium ion transport in cells. AES-350 binds to this receptor and blocks its activity, preventing calcium ions from entering the cell. It also activates other receptors, such as those for vasopressin and bradykinin. This peptide has been shown to be effective in treating cardiac arrhythmias.

Isoagarotetrol is a chemical compound that belongs to the group of volatile oils. It has been shown to inhibit the production of reactive oxygen species, which causes cell damage and inflammation in tissues. Isoagarotetrol also prevents lipid peroxidation and reduces the production of nitric oxide, both of which are involved in the inflammatory process. Isoagarotetrol has been shown to have neuroprotective effects through its inhibition of oxidative stress-induced neuronal death. Isoagarotetrol exhibits pharmacokinetic properties that are dependent on the concentration used and is active against PC12 cells when administered at high concentrations.

Please enquire for more information about UC-514321 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Adenosine 2′,5′-diphosphate sodium is a nucleotide derivative, which is commonly utilized in scientific research, particularly within the fields of biochemistry and molecular biology. This compound is sourced from biochemical processes involving adenosine phosphate derivatives. It plays a vital role in the regulation and modulation of various enzymatic reactions. The mode of action of Adenosine 2′,5′-diphosphate sodium involves serving as an intermediate in nucleotide metabolism and a substrate for enzymes involved in the synthesis of nucleic acids, impacting cellular signaling pathways and energy transfer processes.

ASP3026 is a selective tyrosine kinase inhibitor, which is a synthetic small molecule derived from advanced pharmaceutical research. Its mode of action involves the selective inhibition of the anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase implicated in a variety of cancers. By blocking the activity of ALK, ASP3026 interferes with critical signaling pathways that are essential for cancer cell proliferation and survival.

SB 204741 is a drug that blocks the action of serotonin receptors. It is used in the treatment of autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus. SB 204741 has been shown to reduce levels of cytosolic calcium, which may be due to its inhibition of phospholipase C. This drug also inhibits the polymerase chain reaction and slows cardiac muscle cell growth. In addition, it inhibits the release of growth factor-β1 from platelets and 5-hydroxytryptamine (5-HT) from synaptosomes in rat brain cells. SB 204741 also has a synergistic effect with detrusor muscle relaxants and potentiates the effects of selective 5-HT2C receptor antagonists on 5-HT2B receptors.

Olanzapine d3 is a potent inhibitor of cancer cell growth and tumor formation. It works by inhibiting the activity of kinases, which are enzymes that play a key role in regulating the cell cycle. Olanzapine d3 has been shown to be effective against various types of cancer, including leukemia and solid tumors. This medicinal compound has anticancer properties due to its ability to induce apoptosis, or programmed cell death, in cancer cells. In addition, Olanzapine d3 has been used in Chinese medicine for its protein kinase inhibitory effects and is commonly found in urine samples as a result of metabolism. Overall, this compound shows great promise as an effective treatment option for those suffering from various forms of cancer.